1734
G. Sabitha et al. / Tetrahedron: Asymmetry 22 (2011) 1729–1735
d 7.42–7.22 (m, 5H), 6.92 (d, 1H, J = 1.7 Hz), 6.84–6.75 (m, 2H), 6.58
(dd, 1H, J = 10.7, 17.5 Hz), 5.55 (d, 1H, J = 17.5 Hz), 5.13–5.07 (m,
1H), 5.11 (s, 2H), 3.89 (s, 3H); ESI-MS: 263 [M+Na]+.
110.2, 71.1, 70.7, 70.5, 55.9, 55.9, 44.8, 35.7, 31.2, 21.1; ESI-MS:
617 [M+Na]+; HRMS calcd for C37H39O7: 595.2695; found:
595.2713.
4.1.9. (E,5S)-1,7-Di[4-(benzyloxy)-3-methoxyphenyl]-5-[(4-meth-
oxybenzyl)oxy]-1-hepten-3-one 18
4.1.12. (5S)-5-Acetoxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-3-
heptanone 1
A mixture of compound 4 (1 g, 2.17 mmol), compound 5 (0.52 g,
2.17 mmol), and Grubbs second generation catalyst (10 mol %) in
anhydrous CH2Cl2 (20 mL) was stirred for 48 h at 50 °C. After com-
pletion of the reaction, and concentration of the reaction mixture
under the reduced pressure, the residue was subjected to column
chromatography (eluent: PE–EtOAc, 8:2) to give pure 18 (1.02,
To a stirred solution of 3 (0.15 g, 0.25 mmol) in anhydrous
EtOAc (5 mL) was added a catalytic amount of 10% Palladium ad-
sorbed on carbon and stirred under H2 atmosphere for 6 h. The
reaction mixture was filtered through Celite and the filtrate was
concentrated under reduced pressure. The reaction mixture was
purified by column chromatography (eluent: PE–EtOAc, 7:3) to ob-
70%) as a gummy liquid. ½a D25
ꢀ
¼ þ5:0 (c 1, CHCl3); IR (Neat):
tain 1 (0.08 g, 82%) as a colorless oil. ½a D25
¼ þ5:0 (c 0.5, CHCl3); IR
ꢀ
2923, 2855, 1648, 1594, 1510, 1457, 1258, 1139, 1029 cmꢁ1
;
1H
(Neat): 3433, 2925, 2853, 1722, 1605, 1515, 1458, 1370, 1267,
NMR (CDCl3, 300 MHz): d 7.43–7.26 (m, 16H), 7.17 (d, 2H,
J = 8.3 Hz), 7.01–6.97 (m, 2H), 6.85–6.52 (m, 2H), 5.14 (s, 2H),
5.06 (s, 2H), 4.43 (d, 2H, J = 2.2 Hz), 4.00–3.91 (m, 1H), 3.88 (s,
3H), 3.83 (s, 3H), 3.74 (s, 3H), 2.97 (dd, 1H, J = 6.7, 15.1 Hz), 2.72–
2.54 (m, 3H), 1.89–1.79 (m, 2H); 13C NMR (CDCl3, 75 MHz):
198.7, 159.1, 150.4, 149.7, 149.5, 146.3, 143.1, 137.3, 136.4,
135.2, 130.5, 129.4, 128.6, 128.4, 128.0, 127.6, 127.6, 127.2,
127.1, 124.9, 122.9, 120.1, 114.2, 113.7, 113.3, 112.2, 110.2, 75.4,
71.5, 71.1, 70.8, 55.9, 55.9, 55.2, 45.7, 36.8, 31.2; ESI-MS: 695
[M+Na]+; HRMS calcd for C43H45O7: 673.3165; found: 673.3195.
1153, 1032 cmꢁ1 1H NMR (CDCl3, 300 MHz): d 6.75 (dd, 2H,
;
J = 2.2, 7.5 Hz), 6.62 (d, 2H, J = 2.2 Hz), 6.59 (d, 2H, J = 7.9 Hz)
5.42–5.32 (br s, OH), 5.20–5.13 (m, 1H), 3.87 (s, 3H), 3.84 (s, 3H),
2.79–2.74 (m, 2H), 2.68–2.60 (m, 2H), 2.58–2.44 (m, 4H), 1.97 (s,
3H), 1.87–1.77 (m, 2H); 13C NMR (CDCl3, 75 MHz): 206.9, 170.4,
146.3, 143.9, 143.8, 132.9, 132.7, 120.7, 114.2, 111.0, 110.8, 69.9,
55.8, 55.8, 47.2, 45.0, 35.9, 31.2, 29.2, 21.0; ESI-MS: 439 [M+Na]+;
HRMS calcd for C23H28O7Na: 439.1732; found: 439.1742.
4.1.13. (1S,3R,4E)-1-[4-(Benzyloxy)-3-methoxyphenethyl]-5-[4-
(benzyloxy)-3-methoxyphenyl]-3-hydroxy-4-pentenyl acetate
20
4.1.10. (E,5S)-1,7-Di[4-(benzyloxy)-3-methoxyphenyl]-5-hydr-
oxy-1-hepten-3-one 19
To a stirred solution of (R)-Me-CBS-oxazaborolidine catalyst
(1 M in toluene, 0.12 mL) in anhydrous toluene (3 mL), BH3.DMS
(2 M in THF, 0.35 mL) was added at 0 °C and stirred for 0.5 h. Then
a concentrated solution of keto compound 3 (0.35 g, 0.59 mmol) in
anhydrous toluene (5 mL) was added and the mixture was stirred
for 0.5 h at 0 °C. After monitoring with TLC, the reaction mixture
was quenched with MeOH (1 mL) and followed to warm to room
temperature. The solvent was removed under reduced pressure
and purified by silica gel column chromatography (eluent: PE–
To a solution of 18 (0.95 g, 1.41 mmol) in CH2Cl2/H2O (9:1,
20 mL) was added dichlorodicynoquinone (DDQ) (0.38 g,
1.69 mmol) at 0 °C. The solution was stirred for 0.5 h. After the
reaction was complete, the solution was filtered through a pad of
Celite. The Celite pad was washed with CH2Cl2 (50 mL). The com-
bined filtrate was concentrated and purified by column chroma-
tography (eluent: PE–EtOAc, 7:3) to provide 19 as a pale yellow
solid (0.6 g, 78%). mp = 107 °C; ½a D25
¼ þ78:0 (c 0.25, CHCl3); IR
ꢀ
(KBr): 3482, 3033, 2927, 1624, 1592, 1458, 1262, 1139,
EtOAc, 7:3) to afford 20 (0.3 g, 88%) as
¼ þ4:5 (c 1, CHCl3); IR (Neat): 3497, 2924, 2855, 1730,
1589, 1512, 1458, 1376, 1261, 1139, 1026 cmꢁ1 1H NMR (CDCl3,
a viscous liquid.
1028 cmꢁ1
;
1H NMR (CDCl3, 300 MHz): d 7.45–7.26 (m, 11H),
½ ꢀ
a 2D5
7.04–6.99 (m, 2H), 6.83 (d, 1H, J = 9.0 Hz), 6.76–6.72 (m, 2H),
6.63 (dd, 1H, J = 2.2, 8.3 Hz), 6.52 (d, 1H, J = 15.8 Hz), 5.14 (s, 2H),
5.07 (s, 2H), 4.12–4.01 (m, 1H), 3.90 (s, 3H), 3.86 (s, 3H), 2.83–
2.57 (m, 4H), 1.89–1.61 (m, 2H); 13C NMR (CDCl3, 75 MHz):
200.7, 150.7, 149.7, 149.5, 146.3, 143.7, 137.3, 136.3, 135.2,
128.6, 128.4, 128.0, 127.7, 127.3, 127.2, 127.1, 124.3, 123.0,
120.2, 114.1, 113.3, 112.3, 110.2, 71.1, 70.7, 67.2, 55.9, 55.9, 46.5,
38.3, 31.4; ESI-MS: 575 [M+Na]+; HRMS calcd for C35H36O6Na:
575.2409; found: 575.2428.
;
300 MHz): d 7.42–7.20 (m, 10H), 6.90–6.37 (m, 7H), 6.03–5.85
(m, 1H), 5.56–5.46 (m, 1H), 5.09 (s, 2H), 5.05 (s, 2H) 4.33–4.25
(m, 1H), 3.87 (s, 3H), 3.83 (s, 3H), 2.61–2.47 (m, 2H), 2.05–1.84
(m, 2H), 1.96 (s, 3H) 1.83–1.65 (m, 2H); 13C NMR (CDCl3,
75 MHz): 171.1, 149.6, 149.5, 148.2, 146.3, 137.3, 136.9, 134.6,
133.0, 129.7, 128.4, 128.4, 127.8, 127.7, 127.2, 125.1, 120.0,
119.7, 114.2, 113.8, 112.2, 109.5, 71.4, 71.1, 70.9, 70.3, 55.9, 39.4,
36.4, 31.4, 31.2, 21.2; ESI-MS: 619 [M+Na]+; HRMS calcd for
C37H40O7Na: 619.2671; found: 619.2656.
4.1.11. (1S,4E)-1-[4-(Benzyloxy)-3-methoxyphenethyl]-5-[4-
(benzyloxy)-3-methoxyphenyl]-3-oxo-4-pentenyl acetate 3
Anhydrous Et3N (0.3 mL, 2 mmol), Ac2O (0.1 g, 1 mmol), and a
catalytic amount of DMAP were added to a solution of 19 (0.55 g,
1 mmol) in CH2Cl2 (12 mL) under nitrogen atmosphere at room
temperature. The mixture was stirred at room temperature for
0.5 h. The solvent was removed under reduced pressure, and the
mixture was purified by silica gel column chromatography (eluent:
PE–EtOAc, 9:1) to afford 3 (0.54 g, 92%) as a yellow viscous liquid.
4.1.14. (1S,3R,4E)-3-(Acetyloxy)-1-[4-(benzyloxy)-3-methoxy
phenethyl]-5-[4-(benzyloxy)-3-methoxyphenyl]-4-pentenyl
acetate 21
Anhydrous Et3N (0.12 mL, 0.84 mmol), Ac2O (0.04 g, 0.42 mmol),
and a catalytic amount of DMAP were added to a solution of 20
(0.25 g, 0.42 mmol) in CH2Cl2 (5 mL) under nitrogen atmosphere at
room temperature. The mixture was stirred at room temperature
for 0.5 h. The solvent was removed under reduced pressure, and
the mixture was purified by silica gel column chromatography
(eluent: PE–EtOAc, 9:1) to afford 21 (0.24 g, 92%) as a colorless li-
½
a 2D5
ꢀ
¼ þ7:2 (c 0.9, CHCl3); IR (Neat): 1736, 1654, 1593, 1512, 1453,
1232, 1140 cmꢁ1; 1H NMR (CDCl3, 500 MHz): d 7.47–7.26 (m, 11H),
7.04–7.00 (m, 2H), 6.83 (d, 1H, J = 8.9 Hz), 6.72 (d, 1H, J = 7.9 Hz),
6.70–6.67 (m, 1H), 6.60 (dd, 1H, J = 1.9, 7.9 Hz), 6.52 (d, 1H,
J = 16.8 Hz), 5.30–5.24 (m, 1H), 5.14 (s, 2H), 5.04 (s, 2H), 3.91 (s,
3H), 3.86 (s, 3H), 2.98 (dd, 1H, J = 5.9, 14.8 Hz), 2.74 (dd, 1H,
J = 6.9, 14.8 Hz), 2.67–2.53 (m, 2H), 2.00 (s, 3H), 1.96–1.90 (m,
2H); 13C NMR (CDCl3, 75 MHz): 196.7, 170.5, 150.5, 149.7, 149.5,
146.3, 143.5, 137.3, 136.3, 134.4, 128.6, 128.4, 128.0, 127.7,
127.4, 127.1, 127.1, 124.2, 122.9, 120.0, 114.2, 113.3,, 112.1,
quid. ½a 2D5
ꢀ
¼ ꢁ14:5 (c 1, CHCl3); IR (Neat): 2923, 2854, 1733, 1510,
1457, 1372, 1233, 1139, 1024 cmꢁ1
;
1H NMR (CDCl3, 300 MHz): d
7.43–7.24 (m, 10H), 6.90–6.66 (m, 5H), 6.58 (dd, 1H, J = 1.5,
8.3 Hz), 6.48 (d, 1H, J = 15.8 Hz), 5.89 (dd, 1H, J = 7.5, 15.8 Hz), 5.39
(q, 1H, J = 6.7, 13.5 Hz), 5.12 (s, 2H), 5.07 (s, 2H), 5.00–4.92 (m,
1H), 3.89 (s, 3H), 3.85 (s, 3H), 2.63–2.48 (m, 2H), 2.08–1.97 (m,
2H), 2.02 (s, 3H), 2.01 (s, 3H), 1.92–1.80 (m, 2H); 13C NMR (CDCl3,
75 MHz): 170.5, 170.0, 149.6, 149.6, 148.2, 146.4, 137.3, 136.9,